Mario I Ortiz, Héctor A Ponce-Monter, José A Mora-Rodríguez, Guillermo Barragán-Ramírez, Bertha S Barrón-Guerrero
Journal: European journal of obstetrics, gynecology, and reproductive biology 2011;157(1):22-6
PMID: 21439705
OBJECTIVE
To evaluate the interaction type of the human uterine relaxant effect of the paracetamol-pyrilamine combination (PPC) in vitro.
STUDY DESIGN
Uterine strips were contracted with KCl (60 mM) and treated with vehicle or increasing concentrations of paracetamol (100-3200 μM), pyrilamine (3.2-100 μM) or the PPC. The relaxing effects of the drugs alone and in combination were measured. Isobolographic analysis was used to determine the pharmacologic interaction type.
RESULTS
Paracetamol, pyrilamine and the PPC produced a significant relaxing effect on non-pregnant human uterine strips pre-contracted with KCl (60 mM). The EC30 values for paracetamol and pyrilamine on the uterine contraction were 2391.3±595.3 μM and 14.7±1.7 μM, respectively. The derived experimental EC30 for the PPC was 401.8±129.8 μM. This value was significantly lower (p<0.05) than the theoretical EC30 expected for a purely additive interaction, which was 1203.0±297.7 μM for the PPC. The interaction index (γ) was 0.33±0.14 for PPC, being statistically different from unity.
CONCLUSION
Data suggest that low doses of the PPC can interact synergistically and therefore this drug association may represent a therapeutic advantage for the clinical treatment of dysmenorreic pain.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.